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Abstract
Non-communicable diseases are projected to become the most common causes of death in Africa by 2030. The impact on health of
epidemiological and nutritional transitions in sub-Saharan Africa remains unclear. To assess the trends of dietary fatty acids over time in
Uganda, we examined fatty acids in serum collected from individuals in rural south-west Uganda, at three time points over two decades.
Independent cross-sectional samples of 915 adults and children were selected from the general population cohort in 1990 (n 281), 2000
(n 283) and 2008 (n 351). Serum phospholipid fatty acids were measured by GC. Multivariate regression analyses were performed to compare
the geometric means of fatty acids by time period. Serum fatty acid proﬁling showed high proportions of SFA, cis-MUFA and industrial trans-
fatty acids (iTFA), likely to be biomarkers of high consumption of palm oil and hydrogenated fats. In contrast, proportions of n-6 and n-3
PUFA from vegetable oils and ﬁsh were low. From 1990 to 2008, serum phospholipids showed increases in absolute amounts of SFA (17·3%
increase in adults and 26·4% in children), MUFA (16·7% increase in adults and 16·8% in children) and n-6:n-3 PUFA (40·1% increase in adults
and 39·8% in children). The amount of elaidic acid, iTFA from hydrogenated fats, increased in children (60·1% increase). In this rural Ugandan
population, we show evidence of unfavourable trends over time of dietary fatty acids.
Key words: Nutrition transition: Fatty acids: Biomarkers: Epidemiology: East Africa
Non-communicable diseases (NCD) are projected to become
the most common causes of death in Africa by 2030(1). Despite
this fact, risk factors – including nutritional factors – have not
been fully studied in African populations undergoing epide-
miological and nutritional transitions, with concomitant chan-
ges in lifestyle and diet. In high-income countries, diets began
to shift in the 1970s, from a traditional pattern of high carbo-
hydrate and ﬁbre and low fat and sugar, toward a more glo-
balised ‘Western’ pattern characterised by increased
consumption of processed foods, greater use of edible oils and
sugar-sweetened beverages(2). Similar changes started to
emerge in the 1990s in low- to middle-income countries(2–4).
The nutritional transition has led to an increased consumption of
products that can be harmful to health at high levels, such as
sugar, Na and fat, particularly SFA and industrial trans-fatty acids
(iTFA). In turn, this has had an impact on patterns of cancers,
from one dominated by infection-related cancers to one char-
acterised by cancers related to changing reproductive patterns,
poor diet, excess body fatness and reduced physical activity(5).
Countries in sub-Saharan Africa are clearly undergoing a
nutrition transition(3). More than half of them are still in the early
stage, as illustrated by the ﬁnding that fat, protein and carbo-
hydrate intake are still within those recommended, while a few
have already reached a situation where changes in dietary
patterns are affecting health outcomes in the population(3,6).
Data from the FAO indicated a steady increase in the energy
supply in most sub-Saharan countries over a period of three
decades, protein and fat intake displaying a similar trend(7). An
increase in fat consumption has been shown to be highly
associated with global dietary changes(3). Thus, these data
suggest that measurement of fatty acid intakes might serve as an
indicator of nutrition transition in general.
Abbreviations: GPC, general population cohort; iTFA, industrial trans-fatty acid; NCD, non-communicable disease; TFA, trans-fatty acid.
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Measurement of dietary fatty acids in nutritional epidemiol-
ogy studies has been hampered by substantial measurement
error when using dietary questionnaires. Plasma or serum
phospholipid fatty acid level measurements offer speciﬁc bio-
markers of medium-term (weeks to months) dietary intake of
bioavailable amounts of these nutrients, particularly for fatty
acids that are not endogenously synthesised, such as iTFA and
n-6 and n-3 PUFA(8,9). Thus, the use of speciﬁc biomarkers of
fatty acids is a more rigorous approach to provide a better
understanding of changes in dietary fatty acids in low- to
middle-income countries.
The general population cohort (GPC) set-up in rural south-
western Uganda provided a unique framework to examine the
biomarkers of dietary fatty acids. We measured serum phos-
pholipid fatty acid levels at three time periods, in 1990–1991,
1999–2000 to 2007–2008, and monitored changes over this
period in a representative sample within the GPC.
Methods
Population
The GPC was set up as a population-based open cohort study
established in 1989 to examine trends in HIV prevalence and
incidence in rural south-western Uganda. Since 2010, the sci-
entiﬁc research questions have incorporated the epidemiology
and genetics of both communicable and NCD. The study area is
located in Kyamulibwa sub-county of Kalungu district. The
initial study population of about 10 000 residents comprised a
cluster of ﬁfteen neighbouring villages. From 1999, ten more
adjacent villages with comparable characteristics were added to
the cohort, thereby doubling the population(10).
The study population was recruited through annual house-to-
house rounds of census through which participants for the
medical survey are selected. All residents aged 13 years and
above were included in all the medical survey rounds 1–22
(1989–2011). Children <13 years were also recruited every third
round. Data on health and lifestyle are collected using a stan-
dard individual questionnaire, and blood samples were
obtained and biophysical measurements taken. Blood samples
were transported to MRC/UVRI Laboratories in Entebbe and
stored at –80°C. Overall, more that 95% of households
approached for census participated.
Ethics statement
Study participants provided written informed consent to partici-
pate in the study. Ethical approval for this study was granted by
London School of Hygiene and Tropical Medicine and the Uganda
Virus Research Institute Research and Ethics Committee, and the
study was approved by the Uganda National Council for Science
and Technology. It was also approved by the Ethics Committee of
the International Agency for Research on Cancer (IARC).
Selection criteria
Census rounds 3, 11 and 19 were chosen because of the
inclusion of children. A total of three independent random
samples of 281 individuals (149 adults and 132 children), 283
individuals (166 adults and 117 children) and 351 individuals
(238 adults and 113 children) were selected on the basis of
availability of serum sample and stratiﬁed to provide a 1:1 sex
ratio. Serum samples were shipped to the IARC in Lyon, France.
Laboratory analysis
All measurements of fatty acids were performed at the IARC.
Serum samples were proﬁled for phospholipid fatty acid com-
position by batches of twenty samples, including samples from
eighteen subjects at three time periods (six men, six women and
six children) in random order, and two independent serum
samples as quality controls. The laboratory staff was blinded to
the status of the sample (subject, sex, time period or quality
control). As previously described, total lipids were extracted
from serum samples, phospholipids were puriﬁed by adsorp-
tion chromatography, and fatty acid methyl esters separated
through GC(11). The relative concentration of each fatty acid,
expressed as percentage of total fatty acids, was quantiﬁed by
integrating the area under the peak and dividing the result by
the total area. Fatty acids were also expressed as absolute
concentrations in serum (µmol/l).
Overall (intra-batch and inter-batch) CV for fatty acids, which
were calculated using two serum samples as quality controls
added to each batch, ranged from 0·29% for large peaks such as
palmitic acid, to 7·74% for the smallest peaks such as
18 : 3trans. Speciﬁcally for trans-fatty acids (TFA), the overall
CV were 0·112 for 16 : 1n-9trans, 0·137 for 18 : 1n-9trans, 0·376
for 18 : 2trans,cis, 0·198 for 18 : 2trans,trans, 7·74 for 18 : 3n-
3trans,cis,cis, 0·282 for 18 : 1n-7trans, 1·017 for CLA
10trans,12cis and 0·097 for CLA 9trans,11cis.
Statistical analysis and data treatment
Multivariate regression analyses were performed to compare the
geometric mean levels (mean 95% conﬁdence intervals) of fatty
acids by time period. We calculated the percentage and absolute
amounts of the following groups: SFA, cis-MUFA, ruminant TFA,
iTFA, cis-n-6 PUFA, long-chain n-6 PUFA, n-3 PUFA, long-chain
n-3 PUFA and the ratio of n-6:n-3 PUFA. Analyses were con-
ducted separately in children, men and women and in men and
women combined. Tests for trend were computed using the
time period-speciﬁc geometric means of each fatty acid. The
models were adjusted for age at baseline for men and for
women separately. For children and for adults combined, the
models were adjusted for age at baseline and for sex. All ana-
lyses were performed with STATA version 13 software.
Results
Subject characteristics
Characteristics of the study population are described above and
in a previous report(10). Brieﬂy, the cohort includes all residents
(52% aged ≥13 years, men and women in equal proportions)
within one-half of a rural sub-county, residing in scattered
houses. Characteristics of the study population showed a
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relatively young population, with about 90% of the population
<50 years old, predominantly farmers of three major ethnic
groups. Only 13% of the population attained education beyond
primary level.
Serum phospholipid fatty acid proﬁle
The separation of serum phospholipid fatty acids, particularly
TFA isomers, is shown in Fig. 1. The serum phospholipid fatty
acid proﬁle in the adult study population at baseline (1990–
1991) is provided in Table 1. Due to a lack of appropriate
reference values, we used serum phospholipid fatty acid pro-
ﬁles reported at the same time in other cross-sectional studies of
healthy adults to determine whether our population had been
exposed to low or high fatty acid levels. Serum phospholipid
fatty acid proportions reported in the European Prospective
Investigation into Cancer and Nutrition (EPIC) study(8,9), the
Japan Public Health centre-based prospective study on cancer
and CVD study(12) and the New Zealand National Nutrition
Survey(13) are provided for comparison. In all studies, fatty acids
are expressed in percentage of total fatty acids. Because the
proportions of fatty acids are similar in adult men and women in
the Ugandan population study (data not shown), combined
data are provided for men and women.
In 1990–1991, the fatty acid proﬁle in Ugandan adults is
characterised by a high proportion of SFA (44·53% of total fatty
acids), mainly palmitic acid (27·56%). More striking is the very
high proportion of cis-MUFA (26·30%), mainly oleic acid (20·50%).
In contrast, the proportions of n-6 PUFA (21·66%), mainly linoleic
acid (12·59%) and n-3 PUFA (3·22%) are low. The ratio of n-6:n-3
PUFA is 6·73. The proportion of TFA from industrial processing
(1·72%) is relatively high, mainly as the consequence of a high
proportion of palmitelaidic acid, sixteen-carbon TFA (Fig. 1). In
contrast, the proportion of elaidic acid, the main TFA from
industrial processing, is relatively low, as is the proportion of TFA
from natural sources mainly represented by vaccenic acid.
Trends in serum fatty acids over time
Trends in serum phospholipid fatty acids, expressed in absolute
amounts and in proportions, from 1990 to 2008 are shown in
Table 2 for adults and children.
Notably, there were statistically signiﬁcant increases in
absolute amounts of SFA (17·3% increase in adults and 26·4%
in children) (mainly palmitic acid), of cis-MUFA (16·7% increase
in adults and 16·8% in children) (mainly oleic acid) and of total
n-6 PUFA (20·3% increase in adults and 33·8% in children), as a
consequence of the increasing levels of linoleic acid and long-
chain n-6 PUFA. These trends were present in children and
adults but were stronger in children; an unexplained peak level
of SFA and MUFA was seen in adults in the 1999–2000 collec-
tion. There was an increasing ratio of n-6:n-3 PUFA, rising to
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Fig. 1. Separation of serum phospholipid fatty acids through GC. (a) The separation of fatty acids in a sample from the population study with a high proportion of trans-
fatty acid isomers, while (b) shows a sample with a low proportion of trans-fatty acid isomers. 1, Palmitelaidic acid (16 : 1n-9trans); 2, palmitoleic acid (16 : 1n-9cis);
3, elaidic acid (18 : 1n-9trans); 4, vaccenic acid (18 : 1n-7trans); 5 and 6, linolelaidic acid isomers (18 : 2n-6trans,trans, 18 : 2n-6trans,cis); 7, linolenelaidic acid
(18 : 3n-3trans,cis,cis); 8, conjugated linoleic acid (CLA) 9trans,11cis; 9, CLA 10trans,12cis. Industrial trans-fatty acids (iTFA) included peaks 1, 3, 5, 6 and 7, while
ruminant trans-fatty acids included peaks 4, 8 and 9.
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9·74:1 and 8·43:1 in adults (40·1% increase) and children
(39·8% increase), respectively, in 2007–2008. There was a sig-
niﬁcant increase (of around 60%) in the mean level of elaidic
acid, the main eighteen-carbon monoenoic TFA isomer from
hydrogenated fats in children, with far less of a rise in adults. In
contrast, the levels of palmitelaidic acid showed a decreasing
trend in adults (9% decrease) and children (8% decrease). TFA
from natural animal sources remained very low over time.
Expression of fatty acids, both in proportions and in absolute
amounts, showed similar directions of changes over time;
however, changes are generally more pronounced when
expressed in absolute amounts (Table 2).
Discussion
This study provides the ﬁrst direct evidence of the transition in
serum fatty acid proﬁles in a rural African population over time.
The proﬁle is characterised by high proportions of SFA, cis-
MUFA and iTFA, low proportions of PUFA along with a high
ratio of n-6:n-3 PUFA. This proﬁle persisted from 1990 to 2008,
but with increases in the absolute concentrations of SFA, MUFA,
n-6 PUFA and the ratio of n-6:n-3 PUFA. A speciﬁc TFA isomer
from industrial processing increased in children. Current pro-
ﬁles show high levels of fatty acids that are known to be
deleterious to health.
Compared with data reported for adults in Europe(8),
Japan(12) and New Zealand(13), the fatty acid proﬁle in Ugandan
adults in 1990–1991 is markedly different. The most prominent
difference in Uganda is the far higher proportion of MUFA,
mainly oleic acid. The Ugandan population is also characterised
by higher proportions of SFA, mainly palmitic acid, than
that reported in Europe, close to Japan and lower than New
Zealand. The proportion of n-6 PUFA in Uganda is the lowest of
the four populations compared. Similarly, the proportion of n-3
PUFA is much lower in Uganda than in the three other popu-
lations, particularly Japan. These differences result in Uganda
having the highest ratio of n-6:n-3 PUFA. Among the different
TFA isomers, the proportion of palmitelaidic acid, sixteen-
carbon monoenoic n-9 TFA from industrial processing, is much
higher in Uganda than in Europe, while the proportion of
elaidic acid, the main eighteen-carbon monoenoic n-9 TFA
from industrial processing, is lower in Uganda than in EPIC. The
proportion of TFA isomers from dairy product intake is much
lower in Uganda than in Europe.
High proportions of SFA palmitic acid and MUFA oleic acid in
the GPC in Uganda are likely to be the consequence of high
consumption of palm oil rich in palmitic acid and oleic acid,
commonly used for cooking in Africa(14). High proportions of
TFA from industrial processing are likely to be the consequence
of high dietary intake of palmitelaidic acid, TFA isomer from
partially hydrogenated vegetable oils (PHVO) – these are also
used for cooking as well as being added to a myriad of pro-
cessed foods to cheaply improve the shelf life and palatability.
Major dietary sources of this speciﬁc TFA isomer are deep-fried
foods, bakery products, packaged snack foods, margar-
ines(7,15,16) and also heating/frying and reuse of edible fats/
oils(17). Low proportions of natural TFA in the population study
are likely to be the consequence of low consumption of dairy
foods. Low proportions of n-6 PUFA likely result from low
intake of vegetable oils rich in n-6 PUFA, as reported in a
previous cross-sectional study within the GPC(18). Finally, low
proportions of long-chain n-3 PUFA may reﬂect low intake of
ﬁsh(8).
Trends in the levels of fatty acids from 1990 to 2008 in the
population study showed signiﬁcant increases in SFA (particu-
larly in children), mainly palmitic acid, cis-MUFA, mainly oleic
acid, n-6 PUFA, along with an increased ratio of n-6:n-3 PUFA,
Table 1. Serum phospholipid fatty acid ranges in the general population cohort (GPC) in Uganda, the European Prospective Investigation into Cancer and
Nutrition study, the Japan Public Health centre-based prospective study on cancer and CVD study and a New Zealand National Nutrition Survey
(Mean values, 95% confidence intervals and ranges)
Fatty acids (% total fatty acids)
Adults, GPC Uganda
(1990; n 149)
Adults, Europe(8)
(1992–1998; n 3262)
Adults, Japan(12)
(1994–1995; n 87)
Adults, New Zealand(13)
(1993–1998; n 2416)
Mean 95% CI Mean 95% CI Mean Range Mean Range
Total SFA 44·53 44·12, 44·93 40·46 40·38, 40·53 47·60 42·20–58·90 50·25 43·19–61·22
Palmitic acid (16 : 0) 27·56 27·11, 28·01 25·41 25·33, 25·49 28·70 23·20–36·90 31·73 28·41–37·56
Stearic acid (18 : 0) 15·55 15·19, 15·91 13·99 13·94, 14·05 15·10 11·70–20·80 14·34 11·95–17·79
Total cis-MUFA 26·30 25·56, 27·07 12·80 12·72, 12·88 13·60 10·30–18·40 12·56 9·04–16·85
Palmitoleic acid (16 : 1n-9cis) 1·32 1·24, 1·40 0·60 0·59, 0·60 NA 0·83 0·38–1·43)
Oleic acid (18 : 1n-9cis) 20·50 19·85, 21·16 10·09 10·02, 10·17 8·80 6·30–12·60 10·00 7·57–13·00
Total cis-n-6 PUFA 21·66 20·93, 22·41 37·38 37·25, 37·51 26·50 15·30–33·20 26·26 18·73–38·00
Linoleic acid (18 : 2n-6cis,cis) 12·59 12·03, 13·19 21·83 21·63, 22·02 17·30 9·30–24·30 19·01 12·72–24·54
Long-chain n-6 PUFA 8·76 8·41, 9·12 15·17 15·07, 15·26 NA 7·25 6·01–13·46
Total cis-n-3 PUFA 3·22 2·99, 3·47 6·90 6·83, 6·97 12·40 7·00–20·20 4·74 2·31–7·59
α-Linolenic acid (18 : 3n-3cis,cis,cis) 0·15 0·14, 0·17 0·18 0·18, 0·19 0·20 0·10–1·20 0·24 0·12–0·42
Long-chain n-3 PUFA 2·84 2·63, 3·06 6·69 6·62, 6·76 12·20 5·80–20·80 4·50 2·19–7·17
n-6:n-3 PUFA 6·73 6·21, 7·29 5·42 5·36, 5·48 2·30 0·80–4·40 5·54 5·01–8·11
Total industrial trans-fatty acids 1·72 1·58, 1·86 0·48 0·47, 0·49 NA NA
Palmitelaidic acid (16 : 1n-9trans) 1·28 1·16, 1·41 0·28 0·27, 0·29 NA NA
Elaidic acid (18 : 1n-9trans) 0·18 0·16, 0·19 0·31 0·30, 0·31 NA NA
Total natural trans-fatty acids 0·22 0·19, 0·25 0·80 0·79, 0·82 NA NA
Vaccenic acid (18 : 1n-7trans) 0·08 0·06, 0·09 0·26 0·25, 0·27 NA NA
NA, not available.
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Table 2. Evolution trends of serum phospholipid fatty acids over time in the general population cohort, Uganda
(Mean values and 95% confidence intervals)
Adults Children
Fatty acids (µmol/l) Time period Mean (µmol/l) 95% CI P trend Mean (%) 95% CI P trend Mean (µmol/l) 95% CI P trend Mean (%) 95% CI P trend
Total SFA* 1990–1991 1040·82 944·84, 1146·54 44·53 43·41, 45·67 1087·15 987·6, 1196·75 45·11 44·69, 45·53
1999–2000 1370·70 1250·7, 1502·3 44·62 43·56, 45·70 1247·59 1126·6, 1381·6 46·52 46·06, 46·99
2007–2008 1221·04 1131·06, 1318·2 0·037 44·75 43·86, 45·66 0·752 1374·43 1238·9, 1524·8 0·001 46·02 45·55, 46·49 0·003
Palmitic acid (16 : 0) 1990–1991 673·69 583·74, 777·50 27·56 25·25, 30·07 674·57 613·94, 741·20 26·69 26·22, 27·17
1999–2000 844·79 737·53, 967·65 26·94 24·80, 29·26 802·82 726·39, 887·29 28·65 28·11, 29·19
2007–2008 789·31 704·69, 884·08 0·138 27·66 25·81, 29·64 0·896 833·65 752·96, 922·99 0·002 26·56 26·05, 27·08 0·936
Stearic acid (18 : 0) 1990–1991 332·77 286·90, 385·97 15·55 14·26, 16·95 377·39 340·11, 418·75 17·00 16·65, 17·37
1999–2000 390·25 339·09, 449·13 14·14 13·03, 15·35 407·08 364·50, 454·62 16·51 16·14, 16·89
2007–2008 391·95 348·55, 440·76 0·111 15·69 14·65, 16·80 0·677 503·76 450·20, 563·69 0·0001 18·25 17·84, 18·68 < 0·0001
Total cis-MUFA† 1990–1991 562·28 511·25, 618·41 26·33 25·61, 27·07 562·70 508·55, 622·61 25·50 24·84, 26·17
1999–2000 737·16 673·62, 806·70 26·38 25·70, 27·08 635·61 570··84, 707·73 25·98 25·27, 26·71
2007–2008 656·06 608·48, 707·36 0·041 26·33 25·76, 26·91 0·992 657·37 589·28, 733·34 0·038 24·97 23·30, 24·65 0·301
Palmitoleic acid (16 : 1n-9cis) 1990–1991 30·84 27·47, 34·64 1·32 1·24, 1·40 30·30 27·05, 33·95 1·25 1·19, 1·32
1999–2000 43·48 38·95, 48·53 1·42 1·34, 1·51 36·96 32·75, 41·70 1·38 1·31, 1·46
2007–2008 35·49 32·37, 38·90 0·183 1·30 1·24, 1·37 0·523 34·00 30·07, 38·45 0·153 1·13 1·07, 1·20 0·022
Oleic acid (18 : 1n-9cis) 1990–1991 440·01 399·20, 484·99 20·50 19·88, 21·14 440·45 397·21, 488·39 19·84 19·25, 20·45
1999–2000 582·89 531·54, 639·20 20·77 20·18, 21·38 503·35 451·03, 561·73 20·48 19··83, 21·15
2007–2008 519·98 481·43, 561·61 0·029 20·77 20·27, 21·28 0·536 522·96 467·70, 584·74 0·025 19·96 18·35, 19·59 0·630
Total cis-n-6 PUFA‡ 1990–1991 461·79 416·13, 512·47 21·66 20·93, 22·40 486·21 437·93, 539·82 22·00 21·30, 22·72
1999–2000 624·64 565·96, 689·41 22·27 21·56, 23·00 531·40 475·53, 593·84 21·71 20·97, 22·46
2007–2008 555·74 511·79, 603·46 0·022 22·35 21·76, 22·96 0·174 650·35 580·83, 728·18 0·0001 23·58 22·77, 24·41 0·006
Linoleic acid (18 : 2n-6cis,cis,
cis)
1990–1991 266·48 239·17, 296·90 12·60 12·07, 13·14 275·20 247·25, 306·31 12·56 12·05, 13·09
1999–2000 383·21 345·90, 424·54 13·75 13·21, 14·31 314·06 280·29, 351·90 12·93 12·38, 13·51
2007–2008 318·52 292·41, 346·96 0·050 12·92 12·49, 13·36 0·596 348·41 310·33, 391·16 0·003 12·73 12·17, 13·31 0·642
Long-chain n-6 PUFA 1990–1991 188·53 169·26, 210·00 8·76 8·37, 9·16 204·74 183·08, 228·96 9·16 8·74, 9·60
1999–2000 234·26 211·51, 259·46 8·27 7·92, 8·63 208·84 185·46, 235·18 8·45 8·04, 8·88
2007–2008 228·45 209·77, 248·80 0·012 9·09 8·77, 9·43 0·098 290·55 257·48, 327·87 <0·0001 10·44 9·92, 10·98 0·001
Total cis-n-3 PUFA§ 1990–1991 66·43 58·41, 75·55 3·27 3·04, 3·50 80·63 70·64, 92·03 3·78 3·49, 4·08
1999–2000 69·65 61·66, 78·68 2·60 2·43, 2·78 64·66 56·19, 74·42 2·76 2·54, 3·00
2007–2008 57·05 51·53, 63·17 0·041 2·44 2·31, 2·58 <0·0001 77·16 66·88, 89·02 0·588 2·92 2·68, 3·18 <0·0001
α-Linolenic acid (18 : 3n-3cis,
cis,cis)
1990–1991 2·46 1·32, 4·59 0·15 0·10, 0·24 2·86 1·56, 5·24 0·17 0·11, 0·26
1999–2000 1·68 0·93, 3·04 0·09 0·06, 0·144 2·23 1·17, 4·25 0·12 0·08, 0·20
2007–2008 0·90 0·55, 1·48 0·011 0·06 0·04, 0·09 0·002 1·51 0·78, 2·90 0·149 0·08 0·05, 0·13 0·033
Long-chain n-3 PUFA 1990–1991 57·69 50·32, 66·14 2·89 2·68, 3·10 71·86 62·52, 82·60 3·40 3·13, 3·69
1999–2000 60·57 53·21, 68·95 2·29 2·14, 2·45 56·95 49·12, 66·03 2·47 2·26, 2·69
2007–2008 50·54 45·36, 56·31 0·092 2·20 2·08, 2·33 <0·0001 70·23 60·41, 81·64 0·745 2·68 2·46, 2·93 <0·0001
n-6:n-3 PUFA 1990–1991 6·95 6·45, 7·49 6·63 6·18, 7·11 6·03 5·58, 6·51 5·83 5·41, 6·27
1999–2000 8·97 8·35, 9·63 8·57 8·01, 9·16 8·22 7·57, 8·92 7·87 7·27, 8·51
2007–2008 9·74 9·18, 10·34 <0·0001 9·17 8·67, 9·70 <0·0001 8·43 7·75, 9·16 <0·0001 8·07 7·45, 8·74 <0·0001
Total iTFA|| 1990–1991 37·70 34·94, 40·68 1·72 1·58, 1·86 38·82 35·51, 42·44 1·70 1·58, 1·82
1999–2000 39·51 36·77, 42·46 1·39 1·29, 1·51 36·23 32·95, 39·82 1·44 1·34, 1·55
2007–2008 38·07 35·85, 40·43 0·938 1·51 1·42, 1·62 0·054 38·61 35·07, 42·51 0·896 1·38 1·28, 1·50 0·0001
Palmitelaidic acid
(16 : 1n-9trans)
1990–1991 29·80 27·63, 32·13 1·28 1·15, 1·41 31·34 28·77, 34·13 1·30 1·19, 1·41
1999–2000 29·46 27·43, 31·65 0·96 0·88, 1·06 28·82 26·32, 31·56 1·08 0·98, 1·18
2007–2008 27·40 25·81, 29·08 0·069 1·01 0·93, 1·09 0·001 28·96 26·40, 31·76 0·205 0·97 0·88, 1·06 <0·0001
Elaidic acid (18 : 1n-9trans) 1990–1991 3·08 2·54, 3·73 0·18 0·16, 0·20 2·13 1·62, 2·81 0·13 0·11, 0·16
1999–2000 3·86 3·22, 4·63 0·17 0·15, 0·19 2·79 2·08, 3·73 0·14 0·12, 0·18
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in adults and children. Levels of total iTFA – with palmitelaidic
acid and elaidic acid being the major contributors to total TFA
from frying oils and PHVO – remained stable over time. How-
ever, when distinguishing the two TFA isomers, levels and
proportions of elaidic acid, the main TFA occurring in PHVO,
increased over time in children, while levels and proportions of
palmitelaidic tended to decrease over time, albeit remaining
high compared with European values. This set of data might
suggest that the use of PHVO has further increased in the last
two decades in this rural population in Uganda.
These data indicate unfavourable trends of dietary fatty acids
over time. It is tempting to hypothesise that the unfavourable
trend in this population study in Uganda might reﬂect a global
change in this population’s diet and be a surrogate for an early
stage of nutrition transition in general. This is in line with the
emergence and popularisation of soft drinks and fast foods in
sub-Saharan Africa(3). A study of the diet of urban Ethiopian
adults showed the regular consumption of oil and fat, while the
consumption of fruits and vegetables decreased over time(19).
A dietary survey conducted in Kenya showed signiﬁcant urban/
rural differences in the contribution of macronutrients to total
energy intake, with higher energy from fat and lower energy
from carbohydrates in urban areas(20). This study might also
illustrate differences in nutrition transition stages between urban
and rural areas.
The speciﬁc fatty acid proﬁle in the Ugandan population
study is of concern, as some epidemiological studies reported a
positive association between intake of SFA and iTFA and mor-
tality from CHD, ischaemic stroke and type 2 diabetes(21).
Intake of iTFA, even at low levels, is speciﬁcally associated with
several adverse outcomes, including inﬂammation and cardio-
vascular mortality(22). Although limited, there is growing evi-
dence that increasing blood proportion of iTFA is associated
with an increased risk of weight gain(23) and breast cancer(11,24).
If iTFA are a cause of NCD in the West and yet higher in
levels in Africa, where NCD are less common, this could be
attributable to other characteristics of the population, which
mitigate the increased risks from higher exposure to iTFA. For
examples, risk factors such as smoking, physical activity and
harmful alcohol intake associated with the risk of NCD have
been reported to be rare in Uganda(25). However, the impact of
speciﬁc iTFA isomers on the risk of NCD has not been studied
within the Ugandan population study where the proportion of
some iTFA isomers is higher than that in Europe.
Key strengths of this study are the availability of blood
samples collected from 1990 in adults and children. In addition,
we were able to separate and quantify sixty fatty acids,
including various TFA isomers from natural and industrial pro-
cesses. Finally, we were able to examine the relative con-
centrations as well as absolute concentrations of fatty acids.
Among limitations, long-term storage of blood samples might
have affected fatty acids, particularly PUFA. However, samples
stored between –196°C and –80°C are likely to be stable over
time(26).
In conclusion, these data show evidence of an unfavourable
trend over time of dietary fatty acids in a rural Ugandan
population characterised by increasing levels of SFA, MUFA,
iTFA (speciﬁcally elaidic acid) and n-6:n-3 PUFA. If the majorTa
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sources of these harmful fats are the types of oils and fats used
for cooking, this offers opportunity for policy change to
improve public health in low-income settings. Finally, we also
demonstrate the power of this approach in characterising how
serum fatty acid proﬁles have changed over time, providing a
benchmark for future prospective studies and a comparator for
countries at different stages of nutritional transition.
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